In fact, under normal circumstances, increased ROS levels stimulate cell death, but cancer cells overcome that by activating numerous oncogenes, which then induce nuclear factor erythroid 2-related factor 2 (NRF2) expression. The gene discussed is NFE2L2; the disease is cancer.